Global arabinogalactan market was USD 188.2 million in 2023. Arabinogalactan sales increased by 3.5% per annum from 2024, and the global market would then be USD 200.7 million in 2025. International trade would increase by a 3.7% CAGR to 2025 to 2035, when it would be USD 288.6 million.
Arabinogalactan, plant polysaccharide larch wood extract, is a multi-functional value-added ingredient used in food & beverages, pharma, dietary supplements, and animal nutrition sectors. The trend towards natural prebiotics and immune system modulators has promoted the industry. Its use as soluble fiber in the food business further enhanced its use in the functional foods category.
The second key driver of Arabinogalactan market is rising use of plant and organic molecules in well-being and health. As Arabinogalactan is some prebiotics, it assists intestinal well-being by the well-balanced well-being of gut flora and thus serves as an appropriate synthetic prebiotics alternative. Owing to growing interest in its immunostimulant, it is found used in manufacturing nutraceuticals and food supplements to promote well-being.
Pharma too has been a great contributor in the market by using arabinogalactan as a drug component and drug excipient in drugs. The market still needs to be tapped fully for more difficult naturally occurring types of synthetic excipients.
Geographically, Europe and North America are the biggest buyers of arabinogalactan in the form of diet supplement, dietary supplement, and pharmaceutical and functional food requirements followed by the Asia-Pacific region which is also quickly emerging as the largest market due to increasing awareness towards health along with increasing acceptability of prebiotic-rich food in China, India, and Japan.
| Attributes | Description |
|---|---|
| Estimated Global Arabinogalactan Industry Size (2025E) | USD 200.7 million |
| Projected Global Arabinogalactan Industry Value (2035F) | USD 288.6 million |
| Value-based CAGR (2025 to 2035) | 3.7% |
There will be increased demand at the curve level with growth in the well-being and health market, increased use in animal feed, and ongoing R&D to propel the use into drugs. The food and beverages industry will also utilize arabinogalactan in products in store to sell to other market players.
Explore FMI!
Book a free demo
The following given table gives easy comparison of six months difference in base year (2024) and projected year (2025) of global arabinogalactan market. The report maintains differences of utmost importance in performance and tracks progress in realization of revenues, and thus keeps stake holders posted regarding the trend of growth of the year. H1 is the first half of the year, i.e., January to June. H2 is July to December.
| Particular | Value CAGR |
|---|---|
| H1 | 3.3% (2024 to 2034) |
| H2 | 3.5% (2024 to 2034) |
| H1 | 3.6% (2025 to 2035) |
| H2 | 3.7% (2025 to 2035) |
In the first half (H1) of the 2025 to 2035 period, the corporation will have a CAGR of 3.6% and will be slightly higher at 3.7% in the second half (H2) of the same period. Moving to the next phase, from H1 2025 to H2 2035, the CAGR is expected to increase stepwise. In H1 2025, the industry contributed 30 BPS, while the corporation contributed 20 BPS from the initial estimate in H2 2025.
Through sustained product innovation, over-spending on plant diet food product ingredients, changing consumers' need for natural immune system and prebiotic supplementation, arabinogalactan market will witness steady growth during the next ten years. With every new research on its impact on health, more and more companies will make use of emerging application markets, thereby driving the market development trend.
The arabinogalactan for example being the most relevant is classified as Tier 1 which consists of few large companies dominating the arabinogalactan market and generating considerable revenue, along with similar global distribution networks, and a presence in various sectors such as nutraceuticals, pharmaceuticals, food & beverages and cosmetics. But these companies spend quite a bit on R&D to prove the functional advantages of arabinogalactan, especially as a prebiotic fiber, immune support ingredient and stabilizer.
One prominent Tier 1 case is Lonza Group with its mammalian hemicellulose-derived ResistAid® arabinogalactan, a well-characterized ingredient widely used in dietary supplements and functional foods, with clinical research significant for both FDA and EFSA approvals. TCI America is the other significance player whose supplies high-purity arabinogalactan in the pharmaceutical and laboratory, with significant brand and quality assurance. These companies use sophisticated production capabilities, solid B2B relationships, and regulatory expertise to stay on top.
Tier 2 Moderate revenue but a much higher level of plant-derived polysaccharide and natural additive specialization. Such examples are Ametis JSC which is a Russia-based manufacturer PE focusing on larch-derived arabinogalactan and having major market share in Eastern Europe with increasing exports to North America and Asia.
Arabinogalactan is also available, as part of immune health formulary, from Herb Pharm and other botanical ingredient suppliers. These organizations are known for their cost-effectiveness, custom formulations, and region-based sourcing, providing bulk supply and finished product solutions.
Tier 3 Smaller, emerging companies and regional suppliers targeting niche markets or private label manufacture. These companies typically serve online wellness markets or regional B2B segments, delivering arabinogalactan for pet supplements, natural foods, or cosmetics. Small-volume suppliers in China, India, and Eastern Europe supply arabinogalactan either in bulk quantities or as part of botanical blends.
Flexible pricing, customized solutions, and increased need for natural functional ingredients due to rising health awareness in developing nations drive their growth. Such players also use e-commerce and social media marketing to target health-conscious consumers.
Mastering Sustainable Forestry Practices
Shift: Eco-friendly sourcing of ingredients, particularly from renewable and sustainable forests, is of ever growing significance to consumers and industries alike. Arabinogalactan, mostly derived from larch trees is taking advantage of this change as it has a low environmental impact and meets sustainable forestry criteria. In Europe, especially in Germany and the Scandinavian region, ingredients with forest stewardship certifications and traceable supply chains are marked as favorable ingredients when purchasing nutraceuticals and cosmetics.
Strategic Response: To respond to this eco-sensitive demand, Ametis JSC achieved FSC certification of its EcoLarch® Arabinogalactan, emphasizing sustainable harvesting in Siberia that achieved a 12% boost in European B2B sales.
Under its Green Chemistry initiative, Lonza applied traceable, low-impact extraction methods, with arabinogalactan having low metrics for carbon footprint. In France, Naturex launched an organic-certified arabinogalactan extract, increasing its attractiveness to clean-label cosmetic brands, while Scandinavian supplements companies such as New Nordic used sustainability narratives to gain listings in eco-conscious markets.
Integration in Personalised Nutrition Platforms
Shift: With precision nutrition, wherein supplements are personalized to genomic or microbiome data, the spotlight is shining brightly on arabinogalactan as a prebiotic ingredient of choice. Consumers want gut-health products for life, especially in North America, South Korea and Japan where they are seeking offerings for personalized wellness. The multifunctional benefits of arabinogalactan in supporting immune modulation and microbiome balance is positioning it as the preferred ingredient in DNA-based supplement regimens and custom health kits.
Strategic Response: Viome Life Sciences deployed arabinogalactan in its gut health supplement packs, personalized with AI-driven microbiome analysis, leading to a 15% lift in subscription sales. DayTwo used arabinogalactan in their blood sugar control kits, which are paired with individualized glycemic insights.
In Japan, Fancl Corporation invented a custom immune support powder with arabinogalactan, which suited e-commerce customization, and won 10% growth in online direct-to-consumer outlets. Such companies demonstrate the versatility and effectiveness of arabinogalactan among personal health optimization products.
Fermentation And Biotech Applications Expansion
Shift: Arabinogalactan is making waves in biotech and industrial fermentation as a versatile prebiotic substrate for probiotic culture development, enzyme production, and even bioplastic driving. The biomanufacturing sector in Germany, China, and the USA that requires natural fermentation agents with high yield efficiency and clean-label attributes drive this demand.
Strategic Response: For targeted strains, arabinogalactan in fermentation media from DuPont Nutrition & Biosciences resulted in a 7% increase in overall probiotic yield. Novozymes included arabinogalactan in enzyme production systems; they indicated enhanced fermentation throughput and cleaner processing results.
Using arabinogalactan to create sustainable biopolymer films, Biome Bioplastics reduced their reliance on petrochemical-based plastics and the end result attracted early-adopter eco-packaging clients which ultimately supported a 9 per cent increase in B2B sales in the UK. These companies tout arabinogalactan as a next-generation bioprocessing agent, necessary for green industrial innovation.
Increase in Cognitive Health and Gut-Brain Axis Products
Shift: The cognitive health segment continues to grow at a rapid pace, as consumers look to purchase products that make them feel mentally clear, promote stress support and support memory functions. A growing awareness, particularly among millennials, students and seniors in North America and Europe, of the prebiotic effect of arabinogalactan and its viability as a means of influencing the gut-brain axis is leading to arabinogalactan’s inclusion in nootropic formulations and mental wellness supplements.
Strategic Response: Neurohacker Collective introduced Qualia Focus, combining arabinogalactan and nootropics, boosting sales 13% among urban professionals. Gaia Herbs launched its Brain Boost liquid formula with arabinogalactan as a gut-brain synergy product and saw a 9% gain in DTC channels. In Canada, Herbaland Naturals introduced arabinogalactan gummies with a “Cognitive + Digestive” dual-action label for younger wellness consumers. These brands highlight the multi-dimensional health benefits arabinogalactan can offer for both mental performance and immune resilience.
Emergence in Bioprinting and Medical-Grade Hydrogel Markets
Shift: Properties that have made arabinogalactan a drug formulation excipient can also be leveraged in biomedical technology applications (3D bioprinting, tissue engineering), where there is an interest in the use of the biocompatible, hydrogel-forming and biodegradable polymer. North America, South Korea, and Germany show increasing demand for safe, effective scaffold materials, as regenerative medicine and lab-on-chip technologies continue to flourish internationally.
Strategic Response: CELLINK ( Sweden) incorporated arabinogalactan in bio-ink formulations, resulting in 10% higher cell viability rates in 3D-printed tissues, winning new B2B contracts with research hospitals. Regen HU worked with arabinogalactan as a novel scaffold material for producing bone and skin tissue and received EU cell-matrix type research innovation grants for human cell based medicine.
Advanced BioMatrix (San Diego, CA, USA) launched arabinogalactan in its hydrogel lineup in the USA Targeted for wound care and regenerative therapy markets, proprietary polymers helped sales of medical-grade products increase 6% These firms are capitalizing on the biomedical promise of arabinogalactan, opening new markets beyond nutrition into advanced medical applications.
Increase in Demand for Immune-Enhancing Ingredients in Functional Foods
Shift: Heightened post-pandemic health awareness has resulted in soaring consumer demand for immune health ingredients in regular food and drinks. The immune-modulating properties of arabinogalactan in particular, its ability to support macrophage activation and enhance natural killer (NK) cell activity are why it can be an appealing natural additive in functional foods, drinks, and meal replacements.
This trend is especially prominent in North America, India, and China, where immunity claims are becoming a purchase driver, mostly among parents, seniors, and millennials focused on health.
Strategic Response: Kerry Group launched an arabinogalactan functional beverage line based on Wellmune® ingredients, resulting in a 10% increase in APAC market penetration. Nestlé Health Science added arabinogalactan to its Boost Immune+ nutrition drinks, driving a 9% growth in North American retail sales.
In India, Himalaya Wellness launched its immunity gummies with arabinogalactan and herbal extracts to appeal to the youth demographic, and as a result of the new product, in April it reported that their e-commerce traffic grew 14%. These brands also have been framing arabinogalactan as a clean-label, science-backed immune support ingredient, helping it gain mainstream traction within health-minded food innovations.
The following table shows the estimated growth rates of the top five territories. These markets are set to experience high consumption through 2035.
| Country | CAGR 2025 to 2035 |
|---|---|
| USA | 3.5% |
| Germany | 3.9% |
| China | 3.6% |
| Japan | 3.4% |
| India | 4.0% |
The USA arabinogalactan market is projected to expand in the next few years, due to the activity of rapidly growing industries such as dietary supplements and functional foods. Arabinogalactan, a polysaccharide natural prebiotic fiber is becoming more prominent in the nutraceutical industry as people are becoming more conscientious of their gut health and immune system support.
The increasing trend of using clean-label and plant-based ingredients in food and beverage applications, in addition, is another thing driving demand for the product. The integration of arabinogalactan in pet food and medicines also contributes to the growing presence of the product, furthermore, increasing distribution avenues through ecommerce is expected to help consumers & manufacturers in getting access to the arabinogalactan segment.
Germany's strong leaning toward natural and organic ingredients has made arabinogalactan a sought-after ingredient in those foods and beverages. Prebiotic fibres are becoming increasingly used in food formulations in the country as the focus on gut health and digestive wellness intensifies.
The market's steady growth is supported by promoting the demand for plant-based dietary supplements, as well as rising consumer awareness regarding natural immune boosters. Germany’s pharmaceutical and cosmetic industries have also embraced arabinogalactan, utilizing its functional features to complete further growth opportunities.
This need has been robustly performed in China´s fast-evolving health and wellness space and arabinogalactan is emerging as a trend in functional foods, dietary supplements and pharmaceuticals. As consumers adopt a more health- conscious lifestyle, and preferences towards natural prebiotic fibers shift, arabinogalactan consumption as a digestive health ingredient is on the rise.
Adding to the expansion of market growth is the growth of traditional Chinese medicine (TCM) which has expanded to include modern plant-based ingredients. In addition, the booming pet food sector in China has facilitated the demand for arabinogalactan in high-end pet dietary formulations.
The growing emphasis of Japan on healthy aging and digestive wellness is also driving arabinogalactan demand for dietary supplements and functional foods. As the elderly population grows, there is increasing interest in products that boost gut health and support immune function, and arabinogalactan is finding itself in many different wellness formulations.
Moreover, the high orientation towards research and innovation concerning functional ingredients in Japan has enabled the development of novel usages in cosmetics and pharmaceuticals. The increasing adoption of fiber-rich foods in the Japanese diet also fuels market expansion in this industry.
With a health-conscious population like never before, the demand for dietary supplementation and functional foods has skyrocketed in the country, providing arabinogalactan manufacturers with opportunities in the country. Yet with a growing middle class and greater awareness around gut health, arabinogalactan and other prebiotic fibers are gaining momentum.
The booming nutraceutical industry combined with government initiatives encouraging preventive healthcare preceded the strengthening of the market in the country. Moreover, growing interest in natural and plant-based ingredients in the pharmaceutical, healthcare, and pet food industries propels the arabinogalactan market in India.
| Segment | Value Share (2025) |
|---|---|
| By Type | 55% |
The Arabinogalactan market is segmented on the basis of form into Capsules and Powder. Capsules remain the most popular dosage form because they are simple to consume, allow for precise dosage control, and have a longer shelf life. It is mainly utilized in nutritional supplements and pharmaceutical applications that require precise dosing of probiotics, prebiotics, and immune-boosting compounds.
The increased demand for easy and convenient health supplements has propelled the arabinogalactan powder capsules segment. Increasing preference for plant-based capsule and gelatin-free capsule formulations among vegans and vegetarians also facilitates the growth of this segment. The Powder segment captures a considerable share due to its versatility and its use across various sectors.
Arabinogalactan as a dry powder is an option for use as a functional ingredient in diets and articles for food and beverages, such as superfood, energy bars, smoothies, dairy and bakery. Arabinogalactan powder is also widely used in the pet food & animal feed industry as a gut health, and immune enhancer for livestock. Moreover, it is used to stabilize, emulsify, and add fiber in cosmetics and pharmaceuticals, which also increases demand.
| Segment | Value Share (2025) |
|---|---|
| By Application | 45% |
Application Segmentation of the Arabinogalactan Market: The arabinogalactan market development occurs through Animal Feed, Food and Beverage, Pharmaceuticals, Cosmetics, and Others. The arabinogalactan has a wide array of applications in the Food and Beverage sector as a dietary fibre, prebiotic, and functional component. It is infused into foods such as drinks, snacks, dairy, and baked goods to support gut health, digestion, and immune function.
As gut-friendly and fiber-rich are the new trends, arabinogalactan is being used by manufacturers in food formulations for health and wellness. Another important segment is Animal feed, where arabinogalactan is being used as an immunity booster and prebiotic for animals such as livestock and pets. It aids in digestion, improve absorbtion of nutrients and overall health of the animal. Segment growth is primarily powered by pet food, as consumers become more aware of probiotic and prebiotic pet nutrition.
Pharmaceutical uses of arabinogalactan are increasing, with a prominent focus on immune-supportive formulations and drug delivery systems. It is utilized in capsules, tablets and liquid suspensions to show antioxidant, anti-inflammatory and immune-boosting activity. Emerging research indicating its benefits in gut health, liver function, and cancer prevention have encouraged adoption in the pharmaceutical sector.
Arabinogalactan is used as a hydrating agent, emulsifier, and skin-conditioning agent in the Cosmetics sector. Hyaluronic acid is used in moisturizers, anti-aging creams, and personal care formulations for its moisture retention and product texture enhancement properties.
The market for Arabinogalactans has become highly competitive with leading players like Lonza Group, Ametis JSC and Sensus B.V. consolidating their market share through brand development, product innovation and breakthroughs. These companies shape consumer preference by promoting a wide range of arabinogalactan-based dietary supplements, functional food ingredients, and pharmaceutical formulations in order to meet even growing demand for immune-boosting, prebiotic, and dietary fiber products.
By launching formulations that are high in purity level and clinically validated, they are targeting customers who prefer health and are strengthening their market place. As a result, manufacturers are putting a lot of effort into quality and packaging innovation to remain competitive. Standardized arabinogalactan extracts, with bioactivity and purity that is both consistent and well defined, are now available from many companies.
Apart from this, powder, capsule, and liquid formulations are being rolled out for improved convenience for consumers and to meet a range of preferences. Sustainable, resealable packaging is also on the rise, attracting eco-minded consumers.
For instance:
The global arabinogalactan market is projected to grow at a CAGR of 3.7% during the forecast period.
The market is estimated to reach approximately USD 288.6 million by 2035.
The dietary supplements segment is expected to witness the fastest growth due to increasing awareness of its prebiotic benefits and immune-boosting properties.
Key growth drivers include rising demand for natural dietary fibers, growing application in pharmaceuticals and functional foods, and increasing consumer preference for gut health and immune support products.
Leading companies in the market include BASF SE, DuPont de Nemours Inc., Archer Daniels Midland Company, Cargill Incorporated; Lonza, Pure Encapsulations & Ametis JSC.
Market segmented into Capsule and Powder.
Market segmented into Food and Beverage, Animal Feed, Pharmaceuticals, Cosmetic, and Others.
Market segmented into North America, Latin America, Europe, Asia Pacific, and the Middle East & Africa (MEA).
Japan Avocado Oil Market Analysis - Size, Share & Trends 2025 to 2035
Korea Avocado Oil Market Analysis - Size, Share & Trends 2025 to 2035
Korea Texturized Vegetable Protein Market Analysis – Size, Share & Trends 2025 to 2035
Japan Texturized Vegetable Protein Market Analysis - Size, Share & Trends 2025 to 2035
Western Europe Texturized Vegetable Protein Market Analysis - Size, Share & Trends 2025 to 2035
Western Europe Pea Protein Market Analysis - Size, Share & Trends 2025 to 2035
Arabinogalactan Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
